Publications for Jorma Hinkula
Co-author map based on ISI articles 2007-
Publications mentioned in social media 12 times*
Journal Articles
Karlhans Fru Che, Esaki Muthu Shankar, Sundaram Muthu, Sasan Zandi, Mikael Sigvardsson, Jorma Hinkula, Davorka Messmer and Marie Larsson p38 Mitogen-Activated Protein Kinase/Signal Transducer and Activator of Transcription-3 Pathway Signaling Regulates Expression of Inhibitory Molecules in T Cells Activated by HIV-1-Exposed Dendritic Cells Molecular medicine (Cambridge, Mass. Print), 2012, 18(8), 1169-1182.
Web of Science® Times Cited: 2 |
Andreas Boberg, Alexandra Stålnacke, Andreas Bråve, Jorma Hinkula, Britta Wahren and Nils Carlin Receptor binding by cholera toxin B-subunit and amino acid modification improves minimal peptide immunogenecity ISRN Molecular Biology, 2012, 2012, .
|
Lech Ignatowicz, Jolanta Mazurek, Chaniya Leepiyasakulchai, Markus Sköld, Jorma Hinkula, Gunilla Källenius and Andrzej Pawlowski Mycobacterium tuberculosis infection interferes with HIV vaccination in mice. PloS one, 2012, 7(7), e41205.
|
Luigi Buonaguro, Maria Tagliamonte, Maria Luisa Visciano, Hanne Andersen, Mark Lewis, Ranajit Pal, Maria Lina Torneselloa, Ulf Schroeder, Jorma Hinkula, Britta Wahren and Franco M. Buonaguro Immunogenicity of HIV Virus-Like Particles in Rhesus Macaques by Intranasal Administration Clinical and vaccine immunology, 2012, 19(6), 970-973.
Fulltext Web of Science® Times Cited: 1 |
Chien-Hsing Chang, Jorma Hinkula, Meiyu Loo, Tina Falkeborn, Rongxiu Li, Thomas M. Cardillo, Edmund A. Rossi, David M. Goldenberg and Britta Wahren A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro PLoS ONE, 2012, 7(7), e41235-e41235.
Fulltext |
Lech Ignatowicz, Jolanta Mazurek, Chaniya Leepiyasakulchai, Markus Sköld, Jorma Hinkula, Gunilla Källenius and Andrzej Pawlowski Mycobacterium tuberculosis Infection Interferes with HIV Vaccination in Mice PLoS ONE, 2012, 7(7), e41205-e41205.
Fulltext |
Edwin J. B. Veldhuis Kroeze, Koert J. Stittelaar, Vera J. Teeuwsen, Marcel L Dijkshoorn, Geert van Amerongen, Leon de Waal, Thijs Kuiken, Gabriel P. Krestin, Jorma Hinkula and Albert D. M. E Osterhaus Consecutive CT in vivo lung imaging as quantitative parameter of influenza vaccine efficacy in the ferret model Vaccine, 2012, 30(51), 7391-7394.
|
Susanne E Johansson, Hanna Bauner, Jorma Hinkula, Britta Wahren, Louise Berg and Maria H Johansson Accumulation and activation of natural killer cells in local intraperitoneal HIV-1/MuLV infection results in early control of virus infected cells Cellular Immunology, 2011, 272(1), 71-78.
|
Susanne E Johansson, Erik Rollman, Amy W Chung, Rob J Center, Bo Hejdeman, Ivan Stratov, Jorma Hinkula, Britta Wahren, Klas Kaerre, Stephen J Kent and Louise Berg NK Cell Function and Antibodies Mediating ADCC in HIV-1-Infected Viremic and Controller Patients Viral immunology, 2011, 24(5), 359-368.
Fulltext Web of Science® Times Cited: 10 |
Veronica Tjomsland, Rada Ellegård, Karlhans Fru Che, Jorma Hinkula, Jeffrey D Lifson and Marie Larsson Complement Opsonization of HIV-1 Enhances the Uptake by Dendritic Cells and Involves the Endocytic Lectin and Integrin Receptor Families PLoS ONE, 2011, 6(8), .
Fulltext Web of Science® Times Cited: 2 |
Vicky Jespers, Ali M Harandi, Jorma Hinkula, Donata Medaglini, Roger Le Grand, Christiane Stahl-Hennig, Willy Bogers, Raphaelle El Habib, Frank Wegmann, Carol Fraser, Martin Cranage and Robin J Shattock Assessment of mucosal immunity to HIV-1 EXPERT REVIEW OF VACCINES, 2010, 9(4), 381-394.
Web of Science® Times Cited: 11 |
Andreas Brave, Ulrika Johansson, David Hallengard, Shirin Heidari, Hanna Gullberg, Britta Wahren, Jorma Hinkula and Anna-Lena Spetz Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes VACCINE, 2010, 28(9), 2080-2087.
Web of Science® Times Cited: 5 |
Susanne E Johansson, Bo Hejdeman, Jorma Hinkula, Maria H Johansson, Francois Romagne, Britta Wahren, Nicolai R Wagtmann, Klas Karre and Louise Berg NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients CLINICAL IMMUNOLOGY, 2010, 134(2), 158-168.
Web of Science® Times Cited: 6 |
Jorma Hinkula, Lilian Walther-Jallow, Anna Lauren, Barbro Makitalo, Monica Oberg, Britta Wahren, Eva-Maria Fenyo and Anna-Lena Spetz Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells VACCINE, 2009, 27(46), 6424-6431.
Fulltext Web of Science® Times Cited: 3 |
Andreas Bråve, David Hallengärd, Ulf Schröder, Pontus Blomberg, Britta Wahren and Jorma Hinkula Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses Vaccine, 2008, 26(40), 5075-5078.
|
Andreas Boberg, Andreas Bråve, Susanne Johansson, Britta Wahren, Jorma Hinkula and Erik Rollman Murine models for HIV vaccination and challenge Expert Review of Vaccines, 2008, 7(1), 117-130.
|
Claudia Istrate, Jorma Hinkula, Annie Charpilienne, Didier Poncet, Jean Cohen, Lennart Svensson and Kari Johansen Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice Vaccine, 2008, 26(35), 4594-4601.
|
E. Johansson, Claudia Istrate, A. Charpilienne, J. Cohen, Jorma Hinkula, D. Poncet, Lennart Svensson and K. Johansen Amount of maternal rotavirus-specific antibodies influence the outcome of rotavirus vaccination of newborn mice with virus-like particles Vaccine, 2008, 26(6), 778-785.
Web of Science® Times Cited: 9 |
Jorma Hinkula, Marie Hagbom, Britta Wahren and Ulf Schröder Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice Vaccine, 2008, 26(40), 5101-5106.
|
Andreas Bråve, Kari Johansen, Paolo Palma, Reinhold Benthin and Jorma Hinkula Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant Vaccine, 2008, 26(47), 5957-5966.
Fulltext |
Ingrid Lindh, Irina Kalbina, Sara Thulin, Nikolai Scherbak, Helena Savenstrand, Andreas Brave, Jorma Hinkula, Ake Strid and Soren Andersson Feeding of mice with Arabidopsis thaliana expressing the HIV-1 subtype C p24 antigen gives rise to systemic immune responses APMIS, 2008, 116(11), 985-994.
Fulltext |
Kirsi Harila, Antti Salminen, Ian Prior, Jorma Hinkula and Maarit Suomalainen The Vpu-regulated endocytosis of HIV-1 Gag is clathrin-independent Virology, 2007, 369(2), 299-308.
Web of Science® Times Cited: 12 |
L Buonaguro, C Devito, ML Tornesello, U Schröder, B Wahren, Jorma Hinkula and FM Buonaguro DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity Vaccine, 2007, 25(32), 5968-5977.
Fulltext Web of Science® Times Cited: 36 |
C Istrate, I Douagi, A Charpilienne, GM McInnerney, Å Hidmark, K Johansen, Marie Larsson, Karl-Eric Magnusson, D Poncet, Lennart Svensson and Jorma Hinkula Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus Scandinavian Journal of Immunology, 2007, 65(6), 494-502.
Web of Science® Times Cited: 10 |
Andreas Boberg, Sabrina Dominici, Andreas Brave, Kristian Hallermalm, Jorma Hinkula, Mauro Magnani and Britta Wahren Immunization with HIV protease peptides linked to syngeneic erythrocytes Infectious Agents and Cancer, 2007, 2(1), .
|
Jorma Hinkula Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity Expert Review of Vaccines, 2007, 6(2), 203-212.
Web of Science® Times Cited: 8 |
Erik Rollman, Nathalie Mathy, Andreas Bråve, Andreas Boberg, Anne Kjerrström, Cathy van Wely, Gunnel Engström, Susanne Johansson, Kajsa Aperia, Lars E Eriksson, Reinhold Benthin, Peter Ertl, Jonathan Heeney, Jorma Hinkula, Gerald Voss and Britta Wahren Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model Vaccine, 2007, 25(11), 2145-2154.
Web of Science® Times Cited: 11 |
Daniel X Johansson, Katarina Drakenberg, Kathrin H Hopmann, Alexej Schmidt, Fayezeh Yari, Jorma Hinkula and Mats AA Persson Efficient expression of recombinant human monoclonal antibodies in Drosophila S2 cells JIM - Journal of Immunological Methods, 2007, 318( 1-2), 37-46.
Web of Science® Times Cited: 11 |
Elin Kindberg, Bo Hejdeman, Göran Bratt, Britta Wahren, Bertil Lindblom, Jorma Hinkula and Lennart Svensson A nonsense mutation (428G→A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection AIDS (London), 2006, 20(5), 685-689.
Web of Science® Times Cited: 28 |
Susanne Johansson, David M Goldenberg, Gary L Griffiths, Britta Wahren and Jorma Hinkula Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody AIDS (London), 2006, 20(15), 1911-1915.
Web of Science® Times Cited: 11 |
Kirsi Harila, Ian Prior, Mathilda Sjöberg, Antti Salminen, Jorma Hinkula and Maarit Suomalainen Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag Journal of Virology, 2006, 80(8), 3765-3772.
Web of Science® Times Cited: 38 |
Lars H Lund, Karolina Andersson, Bartek Zuber, Anneli Karlsson, Gunnel Engström, Jorma Hinkula, Britta Wahren and Gösta Winberg Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system Cancer Gene Therapy, 2003, 10, 365-376.
|
Conference Articles
Toomas Timpka, Elin A Gursky, Armin Spreco, Olle Eriksson, Örjan Dahlström, Magnus Strömgren, Einar Holm, Joakim Ekberg, Jorma Hinkula, Jim M Nyce and Henrik Eriksson Predictive value of telenursing complaints in influenza surveillance: a prospective cohort study in Sweden 18th World Congress on Disaster and Emergency Medicine (WCDEM), 28-31 May 2013, Manchester, UK, 2013.
|
Sanna Nystrom, Andreas Brave, Bjorn Rissiek, Daniel X Johansson, Ulf Schroder, Jorma Hinkula and Steven E Applequist DNA-Encoded Flagellin as an Epidermal, Systemic, and Mucosal-Adjuvant in SCANDINAVIAN JOURNAL OF IMMUNOLOGY, vol 73, issue 4, pp 393-393 SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011.
|
S Andersson, A Brave, I Kalbina, H Saevenstrand, Jorma Hinkula and A Strid Feeding of Mice with Transgenic Arabidopsis Thaliana Expressing HIV-1 Subtype C p24 gives Rise to Systemic Immune Response AIDS RESEARCH AND HUMAN RETROVIRUSES, ISSN 0889-2229, vol 24, 2008.
|
L Buonaguro, M Tornesello, Jorma Hinkula, U Schroder, B Wahren and F M Buonaguro Induction of Mucosal Immunity by HIV-1 VLPs Administered Intra-Nasally in Prime/Boost Protocols AIDS RESEARCH AND HUMAN RETROVIRUSES, ISSN 0889-2229, vol 24, 2008.
|
Ph.D. Theses
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.